Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cigna (CI) To Report Earnings Tomorrow: Here Is What To Expect
CI Cover Image
Cigna (CI) To Report Earnings Tomorrow: Here Is What To Expect

In This Article:

Health insurance company Cigna (NYSE:CI) will be reporting earnings tomorrow morning. Here’s what to expect.

Cigna beat analysts’ revenue expectations by 4.5% last quarter, reporting revenues of $65.65 billion, up 28.3% year on year. It was a slower quarter for the company, with full-year operating income guidance missing analysts’ expectations and a significant miss of analysts’ EPS estimates. It added 96,000 customers to reach a total of 17.5 million.

Is Cigna a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Cigna’s revenue to grow 5.5% year on year to $60.42 billion, slowing from the 23.2% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $6.35 per share.

Cigna Total Revenue
Cigna Total Revenue

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Cigna has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 3.5% on average.

Looking at Cigna’s peers in the health insurance providers segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Centene delivered year-on-year revenue growth of 15.4%, beating analysts’ expectations by 8.3%, and Elevance Health reported revenues up 14.8%, topping estimates by 5.3%. Centene traded down 3.3% following the results while Elevance Health was up 4.9%.

Read our full analysis of Centene’s results here and Elevance Health’s results here.

Debates around the economy’s health and the impact of potential tariffs and corporate tax cuts have caused much uncertainty in 2025. While some of the health insurance providers stocks have shown solid performance in this choppy environment, the group has generally underperformed, with share prices down 4.4% on average over the last month. Cigna is up 1.5% during the same time and is heading into earnings with an average analyst price target of $363.05 (compared to the current share price of $337).

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.